Insider Trading History of Steinmetz Michael

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Steinmetz Michael since 2006. The trader's CIK number is 1166285. At the time of the last reporting, Steinmetz Michael was the 10% Owner of Achillion Pharmaceuticals Inc. (stock ticker symbol ACHN). Also see all insider trading activities at Achillion Pharmaceuticals Inc.

Note that in the past STEINMETZ MICHAEL also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pharmasset Inc (VRUS) by Steinmetz Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 VRUS 277,777 $2,499,993 0 $0 0 $0

Yearly summary of insider trading at Avanir Pharmaceuticals (AVNR) by Steinmetz Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 AVNR 0 $0 12,353,458 $58,594,057 0 $0

Yearly summary of insider trading at Achillion Pharmaceuticals Inc (ACHN) by Steinmetz Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 ACHN 0 $0 1,316,956 $9,867,951 0 $0
2010 ACHN 4,875,502 $12,139,999 286,990 $1,067,088 0 $0
2009 ACHN 0 $0 494,776 $1,792,154 0 $0
2008 ACHN 4,654 $10,481 0 $0 0 $0

Yearly summary of insider trading at Zogenix, Inc. (ZGNX) by Steinmetz Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 ZGNX 3,500,000 $7,000,000 0 $0 0 $0
2010 ZGNX 1,750,000 $7,000,000 0 $0 0 $0

Yearly summary of insider trading at Acorda Therapeutics Inc (ACOR) by Steinmetz Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 ACOR 166,667 $1,000,002 0 $0 0 $0


Insider trading activities at 5 companies by Steinmetz Michael:

1. Pharmasset Inc (VRUS)

2. Avanir Pharmaceuticals (AVNR)

3. Achillion Pharmaceuticals Inc (ACHN)

4. Zogenix, Inc. (ZGNX)

5. Acorda Therapeutics Inc (ACOR)

Table 1. Insider trading of Pharmasset Inc (VRUS) by Steinmetz Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-05-02 VRUS Buy 277,777 9.00 2,499,993

Table 2. Insider trading of Avanir Pharmaceuticals (AVNR) by Steinmetz Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-11-08 AVNR Sale 44,626 5.10 227,592
2010-11-09 AVNR Sale 1,200,000 4.81 5,774,400
2010-11-05 AVNR Sale 332,572 4.80 1,597,343
2010-11-03 AVNR Sale 1,400,106 4.52 6,332,679
2010-11-05 AVNR Sale 332,572 4.80 1,597,343
2010-11-03 AVNR Sale 1,400,106 4.52 6,332,679
2010-11-05 AVNR Sale 332,572 4.80 1,597,343
2010-11-03 AVNR Sale 1,400,106 4.52 6,332,679
2010-11-01 AVNR Sale 2,478,142 5.36 13,272,928
2010-10-29 AVNR Sale 1,424,947 5.06 7,215,931
2010-11-02 AVNR Sale 1,290,871 4.49 5,799,883
2010-10-08 AVNR Sale 240,838 3.47 836,671
2010-10-11 AVNR Sale 311,000 3.52 1,093,476
2010-07-13 AVNR Sale 165,000 3.53 583,110

Table 3. Insider trading of Achillion Pharmaceuticals Inc (ACHN) by Steinmetz Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-05-31 ACHN Sale 1,316,956 7.49 9,867,951
2010-08-20 ACHN Buy 4,875,502 2.49 12,139,999
2010-01-11 ACHN Sale 233,990 3.77 881,440
2010-01-06 ACHN Sale 49,400 3.50 173,048
2010-01-07 ACHN Sale 3,600 3.50 12,600
2009-12-24 ACHN Sale 3,600 3.53 12,693
2009-12-21 ACHN Sale 19,100 3.54 67,671
2009-12-23 ACHN Sale 264,900 3.71 981,454
2009-12-16 ACHN Sale 67,800 3.58 242,520
2009-12-17 ACHN Sale 129,476 3.50 453,166
2009-12-18 ACHN Sale 9,900 3.50 34,650
2008-09-05 ACHN Buy 3,054 2.19 6,691
2008-09-08 ACHN Buy 1,600 2.37 3,790

Table 4. Insider trading of Zogenix, Inc. (ZGNX) by Steinmetz Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-09-16 ZGNX Buy 3,500,000 2.00 7,000,000
2010-11-29 ZGNX Buy 1,750,000 4.00 7,000,000

Table 5. Insider trading of Acorda Therapeutics Inc (ACOR) by Steinmetz Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-02-15 ACOR Buy 166,667 6.00 1,000,002

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Steinmetz Michael (10% Owner of Achillion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.